UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

Under normal conditions, "vaccines generate a response through pneumococcus-specific IgG antibodies. However, in patients ...

Adding IgG antibodies against deamidated gliadin peptides (GLA-IgG) to TGA-IgA further improved diagnostic accuracy. The diagnosis of celiac disease in patients with T1D is challenging due to the ...

The combined company will clinically advance Epsilogen's MOv18 IgE antibody in ovarian cancer and TigaTx's anti-EGFR IgA antibody.

Identifying antibodies for 75% of norovirus outbreaks, University researchers took a step forward in creating a vaccine for ...

so both IgA and IgG should be used along with total IgA to determine whether there is an IgA deficiency. AGA: Antigliadin antibody; Anti-tTG: Autoantibodies against the transglutaminase protein ...

Highlights The acquisition combines IgA antibody assets and expertise of Boston-based TigaTx with Epsilogen's assets and expertise in IgE to create the world's leading pan-isotype cancer antibody ...

Serological testing in people who have IgA deficiency:- What is the sensitivity and specificity of IgG tissue transglutaminase (tTG), IgG endomysial antibodies (EMA) and IgG deamidated gliadin peptide ...

Transcutaneous immunization, a topical vaccine application, combines the advantages of needle-free delivery while targeting the immunologically rich milieu of the skin. In animal studies, this ...